Clinical Trial Update: Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Extension study results for pediatric patients with atopic dermatitis treated with pimecrolimus cream in Phase 3 have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus cream (pimecrolimus)

Snippet

Sponsor: Novartis | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED